Download
findings from the drug abuse warning network n.
Skip this Video
Loading SlideShow in 5 Seconds..
Findings from the Drug Abuse Warning Network PowerPoint Presentation
Download Presentation
Findings from the Drug Abuse Warning Network

Findings from the Drug Abuse Warning Network

118 Views Download Presentation
Download Presentation

Findings from the Drug Abuse Warning Network

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Findings from theDrug Abuse Warning Network Immediate and Sustained Release Opioid Analgesics Judy K. Ball, Ph.D., M.P.A. Office of Applied Studies, Substance Abuse and Mental Health Services Administration 9 September 2003

  2. Emergency Departments • Stratified probability sample • Short-term, general, non-Federal hospitals operating 24-hour emergency departments • Representative estimates for coterminous U.S. • 437 hospitals (80%) participated in 2002

  3. DAWN Cases • Age 6-97 treated in ED • ED visit related to drug abuse • Abuse defined by patient’s motive for drug use • Dependence • Psychic effects • Suicide attempt/gesture

  4. Drug Detail in DAWN • Illicit, prescription, OTC drugs • Specificity depends on medical record • Brand (trade) names – MSContin • Chemical names – morphine sulfate • Generic names – morphine • Classes – opiates • Street names • Multiple drugs per visit – drug “mentions”

  5. Mentions of Selected Drugs inED Visits Related to Drug Abuse Source: Drug Abuse Warning Network

  6. ED Mentions of Opiates/Opioids, 2002 Hydrocodone Unnamed Oxycodone All others Morphine 2,775 Fentanyl 1,506 Source: Drug Abuse Warning Network

  7. Narcotic Analgesics, by Type

  8. Unnamed Opiates, ED Mentions Source: Drug Abuse Warning Network

  9. Hydrocodone, ED Mentions Source: Drug Abuse Warning Network

  10. Hydromorphone, ED Mentions Source: Drug Abuse Warning Network

  11. Fentanyl, ED Mentions Source: Drug Abuse Warning Network

  12. Morphine, ED Mentions Source: Drug Abuse Warning Network

  13. Oxycodone, ED Mentions Source: Drug Abuse Warning Network

  14. Oxycodone, ED Mentions Source: Drug Abuse Warning Network

  15. Oxycodone, ED Mentions Source: Drug Abuse Warning Network

  16. Oxycodone, ED Mentions Source: Drug Abuse Warning Network

  17. SR SR IR IR IR 1997 1998 1999 SR IR IR SR SR IR 2000 2001 2002 Oxycodone ED Mentions, 1997-2002

  18. Drugs in Combination, 2002 Source: Drug Abuse Warning Network

  19. Limitations of DAWN • Reportable cases of drug abuse, based on patient’s intent • Variable reporting of nonspecific terms • Cannot distinguish diversion vs. abuse with legitimate prescriptions • No information on health